CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed
Drug / intervention
intra-arterial treatmentprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00146978
NCT00146978Phase 2Completed
CompareCT.gov

A Phase 1/2 Study to Evaluate Intra-Arterial Catheter Directed Therapy for Severe Gastro-Intestinal and/or Hepatic Graft vs. Host Disease (GVHD)

Hadassah Medical Organization·interventional·Posted Sep 7, 2005·Updated Nov 7, 2006

In Brief

A Phase 2 clinical trial evaluating intra-arterial treatment for Graft vs Host Disease. Completed, across 1 site.

Detailed Summary

Graft versus host disease (GVHD) is a major complication of allogeneic bone marrow transplantation (BMT), resulting in death in the majority of steroid resistant patients. The study was designed to assess the efficacy of regional intra-arterial treatment in patients with resistant hepatic and/or gastro-intestinal GVHD.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsGraft vs Host Disease
CountriesIsrael
Collaborators--

Timeline

Phase 2CompletedFinished
200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedSep 7, 2005
Enrollment StartDec 1, 2000
Study CompletionAug 1, 2005
TodayJul 2, 2026
Posted 20.8 years ago

Interventions

intra-arterial treatmentprocedure